Reid Group


Bioanalytical Mass Spectrometry for Proteome and Lipidome Analysis

The primary research focus of the Reid group is the development and application of analytical mass spectrometry-based strategies for chemical and biomolecular analysis from within complex environmental and biological matrices.  This includes the development of chemical and biochemical methods for preteome and lipidome characterisation, and their application toward understanding the role of proteins and lipids in disease, including cancer and neurodegeneration. Visit the Reid Laboratory webpage in the School of Biomedical Sciences, MDHS.

Areas of Interest:

  • Bioanalytical chemistry
  • Lipidomics
  • Proteomics
  • Mass spectrometry
  • Technology Development
  • Colorectal Cancer


  • Mass Spectrometry
  • Chromatography
  • Cell Culture
  • Organic Synthesis
  • Peptide Synthesis


Group Leader

Gavin Reid

PhD Students

Ms Shiyue Qui

Ms Mengxuan Fang

Ms Liuyu (Elle) Peng

Ms Huaqi (Kate) Su

Ms Madison Nuske

Masters Students

Mr Billy Kantharidis



Email: gavin.reid [at]

Tel: (03) 8344 2650

Dr. Gavin E. Reid is the Professor of Bioanalytical Chemistry in the School of Chemistry and a Professor in the Department of Biochemistry and Pharmacology at the University of Melbourne. Over the past 35 years, he has held a variety of technical research positions and academic appointments in Australia and the USA, including at the Ludwig Institute for Cancer Research in Melbourne (1987−1997 and 2002− 2004) and at Michigan State University, MI, USA (2004−2014).  Research in the Reid lab is broadly directed toward the development of analytical biochemistry, mass spectrometry, and associated chemical strategies for quantitative lipidome and proteome analysis, and their application toward identifying the functional role of lipids and proteins in the regulation of cellular function, and in the onset and progression of disease, including colorectal cancer. To date, this inter-disciplinary and highly collaborative research has resulted in >190 peer-reviewed publications, >160 conference and invited seminar presentations, and 4 patents, with funding received from the Australian Research Council, the National Health and Medical Research Council, the USA National Institutes of Health, the USA National Science Foundation, and multiple industry, philanthropic and government groups.  From 2013-2022 he was an Associate Editor for the Journal of the American Society for Mass Spectrometry.  He was President of the Australian and New Zealand Society for Mass Spectrometry from 2016-2020 and served from 2012-2014 on the Board of Directors of the American Society for Mass Spectrometry.  Gavin is currently a member of the Editorial Advisory Boards for the Journal of Lipid Research, and the Journal of Proteome Research.  In 2024, he will serve as Chair of the 25th International Mass Spectrometry Conference, to be held in Melbourne, Australia.